M&A Deal Summary

Quanterix Acquires UmanDiagnostics AB

On June 26, 2019, Quanterix acquired medical products company UmanDiagnostics AB for 23M USD

Acquisition Highlights
  • This is Quanterix’s 1st transaction in the Medical Products sector.
  • This is Quanterix’s largest (disclosed) transaction.
  • This is Quanterix’s 1st transaction in Sweden.

M&A Deal Summary
Date 2019-06-26
Target UmanDiagnostics AB
Sector Medical Products
Buyer(s) Quanterix
Deal Type Add-on Acquisition
Deal Value 23M USD

Target

UmanDiagnostics AB

Umea, Sweden
UmanDiagnostics AB is a provider of Nf-L antibodies and ELISA kits for the detection of Nf-L to advance the development of therapeutics and diagnostics for neurodegenerative conditions. UmanDiagnostics is based in Umea, Sweden.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Quanterix

Billerica, Massachusetts, United States
Category Company
Founded 2007
Sector Information Technology
Employees441
Revenue 121M USD (2023)
DESCRIPTION

Quanterix is a provider of digitizing biomarker analysis for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation, and infectious disease. Quanterix was founded in 2007 and is based in Billerica, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Sweden) 1 of 1
Year (2019) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal